Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06785064 · ClinicalTrials.gov registry record · NA

Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance

A NA study of Weight Loss and Obesity Prevention, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
544
Enrollment target
1
Study location

NCT06785064 is a NA study of Weight Loss and Obesity Prevention that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 544 participants, below the 1,497-participant average among 116 other Weight Loss trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06785064, a NA study of Weight Loss and Obesity Prevention, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
544 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out what combination of components, if any, offers the best support for keeping weight off after someone loses weight. Long term weight loss maintenance is a challenge for many people who lose weight. There are many strategies, or components, people may use to avoid regain, but investigators do not know if there is a best, or optimal, combination of such components that can be done without adding a lot of cost or other burdens for people. * The primary goal of this clinical trial is to identify the optimal package that maximizes weight loss maintenance. * The study also wants to understand the reasons why these components may work and if certain components help specific sub-groups of people. Participants will engage in a 16-week Phase 1 Weight Loss Program. Participants who lose 5% or more of their weight during that program will continue to Phase 2 Extended Care and be randomly assigned to 0, 1, 2, 3, or all of four methods of weight loss maintenance. They will use their assigned package for 12 months. Researchers will compare 16 different possible combinations of components and learn which of the 16 packages offers the best support for keeping weight off. The four components participants could be assigned to in Phase 2 are: 1. Reduced Food Variety: Limiting the variety of foods participants eat by having them choose a few high-calorie, low nutrient foods to eat regularly 2. Home-based Resistance Training: Engaging in exercises that build strength from the comfort of the participant's own home 3. Buddy Training and Support: Having a friend or "buddy" get trained to support the participant 4. Acceptance and Commitment (ACT) Workshops: Having participants learn skills to handle tough thoughts and feelings about weight control in a healthy way Participants will have their weight measured and complete surveys 4 times if they complete both Phase 1 and Phase 2. During Phase 1, participants will attend weekly group sessions and be

Interventions

  • BEHAVIORAL Reduced Food Variety (RFV)
  • BEHAVIORAL Home-based Resistance Training (HBRT)
  • BEHAVIORAL Buddy Training and Support (BTS)
  • BEHAVIORAL Acceptance and Commitment (ACT) Workshops

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 544 participants
Start Date 2025-12-02
Est. Completion 2029-02-28
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06785064

The ClinicalTrials.gov registry entry for NCT06785064 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 544 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,497-participant average among 116 other Weight Loss trials with a reported enrollment target (64% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Weight Loss appearing as the primary indexed condition, and to 4 interventions - of which Reduced Food Variety (RFV) is the first listed.

NCT06785064 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06785064 about?

NCT06785064 is a clinical study titled "Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance". The purpose of this study is to find out what combination of components, if any, offers the best support for keeping weight off after someone loses weight. Long term weight loss maintenance is a challenge for many people who lose weight. There are many strategies, or components, people may use to av...

What is the current status of trial NCT06785064?

This trial is currently recruiting. It is a NA study. The enrollment target is 544 participants. The study started on 2025-12-02. Estimated completion is 2029-02-28.

What conditions does trial NCT06785064 study?

This clinical trial studies the following conditions: Weight Loss, Obesity Prevention, Weight Change, Weight Loss Maintenance.

What interventions are being tested in trial NCT06785064?

The interventions under investigation include: Reduced Food Variety (RFV) (BEHAVIORAL), Home-based Resistance Training (HBRT) (BEHAVIORAL), Buddy Training and Support (BTS) (BEHAVIORAL), Acceptance and Commitment (ACT) Workshops (BEHAVIORAL).

Who is sponsoring clinical trial NCT06785064?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06785064 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.